Denali teases early data for enzyme replacement therapy in rare disease

Denali revealed new topline data Wednesday for an early-stage program that's a part of the FDA’s Operation Warp Speed for rare diseases. The program, DNL126, is an enzyme replacement therapy for Sanfilippo ...